Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site

被引:97
|
作者
Durdagi, Serdar [2 ]
Senturk, Murat [1 ]
Ekinci, Deniz [3 ,4 ]
Balaydin, Halis Turker [5 ]
Goksu, Suleyman [6 ]
Kufrevioglu, O. Irfan [6 ]
Innocenti, Alessio [7 ]
Scozzafava, Andrea [7 ]
Supuran, Claudiu T. [7 ]
机构
[1] Ibrahim Cecen Univ Agri, Sci & Art Fac, Dept Chem, TR-04100 Agri, Turkey
[2] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada
[3] Ondokuz Mayis Univ, Fac Agr, Dept Agr Biotechnol, TR-55139 Samsun, Turkey
[4] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany
[5] Artvin Coruh Univ, Fac Educ, TR-08100 Artvin, Turkey
[6] Ataturk Univ, Fac Sci, Dept Chem, TR-25240 Erzurum, Turkey
[7] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
关键词
Carbonic anhydrase; Phenol; Sulfonamide; Dimethoxy-benzene; Phenolic acid; Docking; Enzyme inhibition; ISOZYME-II; CRYSTAL-STRUCTURE; SALICYLIC-ACID; ACTIVATORS; SULFONAMIDES; COUMARINS; DESIGN; AGENTS; ADDUCT; SERIES;
D O I
10.1016/j.bmc.2011.01.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbonic anhydrases (CAs, EC 4.2.1.1) are inhibited by sulfonamides, inorganic anions, phenols, coumarins (acting as prodrugs) and polyamines. A novel class of CA inhibitors (CAIs), interacting with the CA isozymes I, II (cytosolic) and IX, XII (transmembrane, tumor-associated) in a different manner, is reported here. Kinetic measurements allowed us to identify hydroxy-/methoxy-substituted benzoic acids as well as di-/tri-methoxy benzenes as submicromolar-low micromolar inhibitors of the four CA isozymes. Molecular docking studies of a set of such inhibitors within CA I and II allowed us to understand the inhibition mechanism. This new class of inhibitors binds differently compared to all other classes of inhibitors known to date: they were found between the phenol-binding site and the coumarin-binding site, filling thus the middle of the enzyme cavity. They exploit different interactions with amino acid residues and water molecules from the CA active site compared to other classes of inhibitors, offering the possibility to design CAIs with an interesting inhibition profile compared to the clinically used sulfonamides/sulfamates. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1381 / 1389
页数:9
相关论文
共 49 条
  • [21] Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111
    Lomelino, Carrie L.
    Mahon, Brian P.
    McKenna, Robert
    Carta, Fabrizio
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (05) : 976 - 981
  • [22] Carbonic anhydrase inhibitors:: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides -: a new zinc-binding function in the design of inhibitors
    Winum, JY
    Innocenti, A
    Nasr, J
    Montero, JL
    Scozzafava, A
    Vullo, D
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2353 - 2358
  • [23] Quantitative Characterization of the Interaction Space of the Mammalian Carbonic Anhydrase Isoforms I, II, VII, IX, XII, and XIV and their Inhibitors, Using the Proteochemometric Approach
    Rasti, Behnam
    Karimi-Jafari, Mohammad H.
    Ghasemi, Jahan B.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 88 (03) : 341 - 353
  • [24] Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation
    Moi, Davide
    Nocentini, Alessio
    Deplano, Alessandro
    Balboni, Gianfranco
    Supuran, Claudiu T.
    Onnis, Valentina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 182
  • [25] Carbonic anhydrase inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety
    Sethi, Kalyan K.
    Vullo, Daniella
    Verma, Saurabh M.
    Tanc, Muhammet
    Carta, Fabrizio
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (19) : 5973 - 5982
  • [26] Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: Identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones
    Sarikaya, Busra
    Ceruso, Mariangela
    Carta, Fabrizio
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (21) : 5883 - 5890
  • [27] Kinetic and docking studies of cytosolic/tumor-associated carbonic anhydrase isozymes I, II and IX with some hydroxylic compounds
    Durdagi, Serdar
    Korkmaz, Neslihan
    Isik, Semra
    Vullo, Daniela
    Astley, Demet
    Ekinci, Deniz
    Salmas, Ramin E.
    Senturk, Murat
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (06) : 1214 - 1220
  • [28] Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors
    Nocentini, Alessio
    Moi, Davide
    Balboni, Gianfranco
    Onnis, Valentina
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2018, 77 : 293 - 299
  • [29] Development of novel organometallic sulfonamides with N-ethyl or N-methyl benzenesulfonamide units as potential human carbonic anhydrase I, II, IX and XII isoforms' inhibitors: Synthesis, biological evaluation and docking studies
    Gallardo, Miguel
    Arancibia, Rodrigo
    Supuran, Claudiu T.
    Nocentini, Alessio
    Villaman, David
    Toro, Patricia M.
    Munoz-Osses, Michelle
    Mascayano, Carolina
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2024, 260
  • [30] Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors
    Nocentini, Alessio
    Moi, Davide
    Deplano, Alessandro
    Osman, Sameh M.
    AlOthman, Zeid A.
    Balboni, Gianfranco
    Supuran, Claudiu T.
    Onnis, Valentina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186